Back to search
FDAFDA · Food and drugs·Recall number Z-3185-2024

Acceava Respiratory Strep A, CLIA Waived, Catalog Number 4580295008

Published September 25, 2024 · Recall initiated: August 20, 2024

Summary

FDA records medical device Class II recall Z-3185-2024, published September 25, 2024 and initiated August 20, 2024. Recalling firm: Cypress Medical Products LLC; Status: Ongoing; Reported quantity: 5 kits; Lot: GTIN: 10815845020031; All Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to a classification error in our inventory management system, these medical devices were shipped to customers that did not have the requisite license to purchase such devices.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cypress Medical Products LLC
Distributor
US Nationwide distribution.
Lot
GTIN: 10815845020031; All Lots
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Acceava Respiratory Strep A, CLIA Waived, Catalog Number 4580295008 recalled?

Yes. FDA published recall Z-3185-2024 on September 25, 2024. Reported hazard: Due to a classification error in our inventory management system, these medical devices were shipped to customers that did not have the requisite license to purchase such devices.

What should I do if I have this product?

Voluntary: Firm initiated · Letter